We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Must be the drugs

28 December 2018 By John Foley

Pot retailer Green Growth is mulling a hostile all-stock bid for the $2 bln Canadian grower. Synergies are negligible, the 46 pct premium is illusory and the target would lose listings in New York and Toronto. A brave try, but one Aphria would have to be high as a kite to accept.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)